C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/7088 (2006.01) C12N 9/02 (2006.01)
Patent
CA 2526393
The present invention provides antisense oligonucleotides directed to a mammalian ribonucleotide reductase R1 gene and combinations of the antisense oligonucleotides with one or more chemotherapeutic agents for use in the treatment of cancer.
La présente invention concerne des oligonucléotides antisens dirigés contre un gène R1 de la ribonucléotide réductase de mammifères ainsi que des associations desdits oligonucléotides antisens avec un ou plusieurs agents chimiothérapeutiques destinés à être utilisés dans le traitement du cancer.
Wright Jim A.
Young Aiping H.
Genesense Technologies Inc.
Lorus Therapeutics Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Antisense oligonucleotides directed to ribonucleotide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides directed to ribonucleotide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides directed to ribonucleotide... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1969931